Abstract
Abstract: The ketogenic diet (KD) has made a breakthrough in the treatment of glioma and has become a research hotspot because of its unique dietary structure, particularly as an auxiliary strategy for anti-tumor. This article reviews the application and mechanism of KD combined with other antitumor methods, such as chemoradiotherapy, immunotherapy, molecularly targeted drugs, antiangiogenic drugs, glucose-targeted drugs, hyperbaric oxygen, ketone bodies, and intestinal flora, aiming to provide a theoretical basis for the clinical application of KD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
